4925 Results

People

  1. Giralt
    Giralt
  2. Berger
    Berger
  3. Morrow
    Morrow
  4. Horwitz
    Horwitz
  5. Ladanyi
    Ladanyi
  6. Lee
    Lee
  7. Adusumilli
    Adusumilli
  8. Hyman
    Hyman
  9. Perales
    Perales
  10. Solit
    Solit

Groups

  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)
  7. Center for Hematologic Malignancies (764)
  8. Hematologic Malignancies, Division of (714)
  9. Department of Pathology and Laboratory Medicine (653)
  10. Population Sciences Research Program (632)
  1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Breast carcinoma with 21-gene recurrence score lower than 18: Rate of distant metastases in a large series with clinical follow-up
    Meeting Abstract

    Wen, H. Y.; Krystel-Whittemore, M.; Patil, S.; Pareja, F.; Bowser, Z. L.; Dickler, M.; Norton, L.; Morrow, M.; Hudis, C.; Brogi, E.
    Cancer Research (2017)

    Fulltext@MSK | Save
  • P-selectin is a nanotherapeutic delivery target to the tumor microenvironment
    Meeting Abstract

    Heller, D. A.
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Recurrent SRF-RELA fusions define a novel subset of cellular myofibroblastic neoplasms in the spectrum of cellular myofibroma/myopericytoma: A potential diagnostic pitfall with sarcomas with myogenic differentiation
    Meeting Abstract

    Antonescu, C. R.; Sung, Y. S.; Zhang, L.; Agaram, N. P.; Fletcher, C. D. M.
    Modern Pathology (2017)

    Fulltext@MSK | Save
  • EWSR1 fusions with CREB family transcription factors define a novel myxoid mesenchymal tumor with predilection for intracranial location
    Meeting Abstract

    Kao, Y. C.; Sung, Y. S.; Zhang, L.; Vaiyapuri, S.; Rosenblum, M.; Antonescu, C. R.
    Modern Pathology (2017)

    Fulltext@MSK | Save
  • VADIS trial: Phase II trial of the nelipepimut-S peptide vaccine in women with DCIS of the breast
    Meeting Abstract

    Mittendorf, E. A.; Plitas, G.; Garber, J.; Crew, K.; Heckman-Stoddard, B.; Wojtowicz, M.; Vornik, L.; Peoples, G. E.; Brown, P. H.
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Changing paradigms in the local therapy of breast cancer: Making less more
    Meeting Abstract

    Morrow, M.
    Cancer Research (2017)

    Fulltext@MSK | Save
  • The latest breakthroughs on the translational aspects of DNA repair pathways
    Meeting Abstract

    Powell, S. N.
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Efficacy and gene expression results from SOLTI1007 NEOERIBULIN phase II clinical trial in HER2-negative early breast cancer
    Meeting Abstract

    Prat, A.; Ortega, V.; Villagrasa, P.; Pare, L.; Galvan, P.; Oliveira, M.; Nuciforo, P.; Lluch, A.; Morales, S.; Amillano, K.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • A phase 2 study of abemaciclib plus pembrolizumab for patients with hormone receptor positive (HR+), HER2 negative (HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Rugo, H.; Tolaney, S.; Dickler, M.; Kabos, P.; Ho, C. L.; Wildiers, H.; Jerusalem, G.; Ales-Martinez, J. E.; Hossain, A.; Johnston, E.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Primary analysis of BERENICE: A phase II cardiac safety study of pertuzumab, trastuzumab, and neoadjuvant anthracycline-based chemotherapy in patients with locally advanced, inflammatory, or early-stage, unilateral, and invasive HER2-positive breast cancer
    Meeting Abstract

    Swain, S. M.; Ewer, M. S.; Viale, G.; Delaloge, S.; Ferrero, J. M.; Verrill, M.; Colomer, R.; Vieira, C.; Werner, T. L.; Douthwaite, H.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save